| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 0.001 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |